Abstract
Stem cell therapy - the emerging therapy area that is drawing the attention
of the pharmaceutical players worldwide - refers to the therapy wherein a
damaged tissue that cannot heal itself is repaired by the use of stem cell.
The market for stem cells is constantly evolving, with researches going on to
exploit the true potential of the market worldwide. Stem cell has emerged as
an important market in the US which continues to witness massive investments
in this research arena. The US has seen some major achievements in the
treatment of the diseases using stem cell technologies. The market has shown
remarkable growth since 2005, when the first stem cell product entered into
the market. The stem cell therapy market reported a CAGR growth of around 18%
in a short period spanning from 2005 to 2008, says our new research report,
"“US Stem Cell Market Analysis”.
The revenue is expected to increase manifold with new stem cell products
likely to enter into the market in 2009 and onwards. As the market currently
remains in its nascent stage, our team of experts has done thorough analysis
of the prevailing trends and developments of the stem cell market in the US.
We have studied the US stem cells product market in terms of adult stem cells
and embryonic stem cells. This report provides extensive research on the
current status and future outlook of these two segments.
We have found that the US embryonic stem cell product market suffered a
setback due to the eight year old ban on federal funding of the embryonic stem
cells imposed under the Bush Administration. The recent reversal of the ban by
Obama on federal funding for the research has opened up new avenues for the
market. On technological front, this report studies the stem cells market as
therapeutic banking and cellular therapeutics.
The prevalence of the major diseases among people with no permanent cure
available and the dependency on medicines for sustainability and well-being
provides the ready market for the stem cell companies to tap.
“US Stem Cell Market Analysis” provides extensive research and
thorough analysis of the current industry trends driving the growth of stem
cell market in the US. This report highlights the emerging segments in the
market alongwith their market potential to serve the country' s population. The
report will help the clients to understand the market dynamics and get an
insight of the current and the future outlook of stem cells market in the US
| 
View Cart
